MedTrace Logo

The Effect of Dexmedetomidine on the Emergence Agitation in Nasal Surgery

NCT01513772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-08-09

No results posted yet for this study

Summary

The investigators examined the effect of dexmedetomidine on the emergence agitation and postoperative quality of recovery in nasal surgery

Conditions

  • Airway Extubation

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine(4㎍/mL) : 0.4㎍/kg/hr infusion until extubation

DRUG

Normal saline 0.9%

Normal saline(guess as 4㎍/mL) : 0.4㎍/kg/hr infusion until extubation

Sponsors & Collaborators

  • Severance Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01513772 on ClinicalTrials.gov